A scheme to stabilize minor slope instabilities is currently being developed. The scheme uses a distributed network of “pins” fabricated from recycled plastics and other waste materials to provide positive reinforcement of a soil mass. Although the application is similar to stabilization of slopes with soil nails or micropiles, significant modifications to conventional design and construction are necessary to account for the reduced strength and increased ductility and creep exhibited by plastic materials compared with concrete and steel. Using recycled plastics has the advantage of providing reinforcing members with low susceptibility to degradation and provides a market for materials that otherwise might be buried in a landfill. An extensive investigation is under way to evaluate the potential for using recycled plastic pins (RPPs) to stabilize minor slope failures. This evaluation includes quantification of appropriate material and engineering properties of RPPs, evaluation of RPP resistance to degradation in various environments, development and evaluation of suitable mechanisms for installing RPPs, evaluation of RPP resistance to driving stresses, development of a design procedure that accounts for the reduced structural capacity of RPPs compared with steel or concrete members, and installation and monitoring of several full-scale field demonstration sites. The ongoing evaluation program that is described focuses on laboratory tests to determine fundamental engineering and material properties, field driving trials to evaluate potential driving mechanisms, and preliminary development of a suitable procedure for designing RPP stabilization schemes.
No abstract
ACK1 is an oncogene in the ACK family of non-receptor tyrosine kinases (NRTK). In humans, ACK1 is located on chromosome 3q29, a region that is frequently amplified in a variety of cancers including prostate, lung and breast. The ACK kinase family has a unique domain arrangement with, most notably, a putative ubiquitin association (UBA) domain at their C-termini. In the present study, we focus on understanding the ubiquitin-binding nature of the ACK1 UBA and its role in kinase regulation. Structural modeling and sequence analysis suggest that the ACK1 UBA diverges from many other UBAs but shares similarities with the ACK family kinase, TNK1. We found that the ACK family UBA has a remarkably high affinity for diverse poly-ubiquitin linkages with dissociation constants in the low nanomolar range. Our preliminary data suggest that a non-covalent interaction between the UBA and ubiquitin is necessary for ACK kinase activation in cell culture systems. Furthermore, our preliminary data suggest this interaction is sufficient to induce ACK1 activation in vitro. In support of the idea that the UBA is important for ACK1 activation, we identified a variety of cancer patient mutations that disrupt the ACK1 UBA, which we are currently testing for oncogenic activity. Lastly, we have identified small molecule inhibitors of ACK with low nanomolar IC50 values in ACK1-driven cells. Altogether, our data suggest a model of ACK1 activation that involves direct, non-covalent interaction with ubiquitin and potential therapeutic approaches to inhibit ACK1 in cancer. Citation Format: Eranga Roshan Balasooriya Loku Balasooriyage, Jacob Owen, Jack Gashler, Colin Muir, Katie Pennington, James Moody, Joshua L. Andersen. Regulation of the oncogenic tyrosine kinase ACK1 through ubiquitin-dependent mechanism [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2304.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.